Colonic microflora imbalance and diverticular disease

Digestive and Liver Disease

Volumn 42, Issue 6, 2010, Pages 457-459

  Tursi, Antonio ^a  

^a ASL BAT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; RIFAXIMIN;

BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; COLON FLORA; DIETARY FIBER; DIVERTICULOSIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LETTER; NONHUMAN; PRIORITY JOURNAL; REMISSION;

EID: 77952744897     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.08.004     Document Type: Letter

References (5)

1. Ojetti V., Gigante G., Ainora M.E., et al. Microflora imbalance and gastrointestinal diseases. Dig Liver Dis 2009, 3(Suppl. 3):35-39.
2. Tursi A., Papagrigoriadis S. Review article: the current and evolving treatment of colonic diverticular disease. Aliment Pharmacol Ther 2009, 30:532-546.
3. Tursi A., Brandimarte G., Giorgetti G.M., Elisei W. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. World J Gastroenterol 2005, 11:2773-2776.
4. Comparato G., Fanigliulo L., Cavallaro L.G., et al. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. Dig Dis Sci 2007, 52:2934-2941.
5. Tursi A., Brandimarte G., Daffinà R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 2002, 34:510-515.